World Vaccine Congress Europe 2015

4 reasons for why you should attend

Delve into new technologies for vaccine development, including nanotech, synthetic biology and new-generation adjuvants

Hear clinical phase I, II and III data from leading biotechs and big pharma

Gain updates on the latest discovery-stage prophylactic and therapeutic vaccines

Explore the latest methods for improving bioprocessing and manufacturing methodologies for current and future vaccines

The World Vaccine Congress Europe Story

Europe’s most successful vaccine event is now entering its 16th year.

For 15 years the World Vaccine Congress in Europe has been the leading event to talk about scientific advances and find new business opportunities within the vaccine sector and this year is no exception.

From humble beginnings as a small conference with a handful of exhibition stands, in 2014 we had 65 sessions, over 75 speakers and 29 sponsors.

The agenda was built to reflect the new activities in the vaccine industry. From a focus to what is going on in the cancer or influenza vaccine fields to parallel tracks on discovery and pre-clinical validation, clinical trials and manufacturing methods there was something for the full range of people who work to get a vaccine to market.

For 2015 we are going to be building on previous success by making sure that the agenda delves into what is truly innovative in the sector right now and the speakers are true disrupters and trend-setters.

The organisers, Terrapinn, design, produce and create conference agendas that are truly world-class. Our formats are unique. Our keynotes are genuine innovators and thought leaders. Our content and topics are relevant, well-researched and at the cusp of global and regional trends.

As they will attest, for vaccine buyside companies and solutions providers alike, the World Vaccine Congress Europe is a place where collaborations are founded and deals are sparked.

Make sure you don’t miss the chance to get involved in the event!